Bayer said second-quarter revenues edged up by nearly 2 percent on the strength of its prescription drug sales.

But the Germany-based conglomerate revised its earnings and sales estimates for the full year because of steep declines in revenues for its pesticides and other agricultural products.

The company said its crop science segment took a major hit in Brazil where it experienced product returns.

Global sales were 12.2 billion euros ($14.2 billion).

Advertise with us

Earnings before interest, taxes, depreciation and amortization and other costs rose to 3.1 billion euros, just beating analysts average estimates of 3 billion euros.

Bayer hopes to close its takeover of U.S.-based seed company Monsanto by the end of the year but could still face antitrust review issues in Europe.

Bayer has about 1,600 employees in the Pittsburgh region including administrative personnel and workers at a Bayer HealthCare unit.